Medication info

Simvastatin/Ezetimibe Tablets 10/20 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Hanpoong Pharmaceutical Co., Ltd.
Appearance
White to off-white, bilaterally convex rectangular tablets
Packaging
30 tablets/PTP [10 tablets/PTP X 3]
Approval status
Expired

MFDS item code 201905599 · Approved 2019.08.08

This product's status changed to Expired on 2024.08.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine in these patients with caution and monitor them closely (see 5. General Precautions under Precautions for Use). Use in elderly patients No dose adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic kidney failure
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apoB protein, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol, often referred to as 'good cholesterol.' It can be used in patients with homozygous familial hypercholesterolemia when other treatments are ineffective or as adjunct therapy. This drug must be used in conjunction with dietary management, and dyslipidemia caused by other factors should be addressed first. It’s important to check lipid levels before treatment, and in the case of acute coronary events, lipid testing should be conducted as soon as possible. Through these processes, the risk of atherosclerotic vascular disease due to hypercholesterolemia can be effectively reduced. In summary, this drug is used to improve lipid levels associated with hypercholesterolemia and enhance vascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this medicine once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Use in patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine in these patients with caution and monitor them closely (see 5. General Precautions under Precautions for Use). Use in elderly patients No dose adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.

Precautions

This drug can cause muscle-related side effects, such as myopathy and rhabdomyolysis. The risk of these increases, particularly at high doses, so patients should report muscle pain or weakness to their doctor immediately. Patients with liver dysfunction or liver disease should not use this medication. Women who are pregnant or breastfeeding should also avoid this drug and consult a doctor if planning to become pregnant. The risk of muscle side effects can increase when this drug is taken with certain other medications, so patients should consult their doctor about any other medications they are taking. Elderly patients over the age of 65, or those with hypothyroidism or decreased kidney function must use this drug with caution. Regular liver function and muscle-related tests should be conducted during treatment, and any abnormal symptoms should be reported to healthcare providers immediately. This medication should be used with caution in children and adolescents, especially not recommended in patients under 10 years of age. Since there is no specific antidote for overdose, appropriate treatment should be sought at the hospital immediately.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 98 more
  • abdominal pain
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • dysgeusia
  • external ophthalmoplegia
  • facial paresis
  • tremor
  • dizziness
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • severe myasthenia gravis
  • oculobulbar myasthenia
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • fatty liver changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • loss of appetite
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stool
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

White to off-white, bilaterally convex rectangular tablets

Package unit

30 tablets/PTP [10 tablets/PTP X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.